Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1987 3
1988 2
1989 3
1990 8
1991 1
1992 3
1993 3
1994 8
1995 7
1996 11
1997 9
1998 3
1999 19
2000 12
2001 10
2002 25
2003 32
2004 43
2005 51
2006 84
2007 86
2008 106
2009 146
2010 165
2011 173
2012 231
2013 253
2014 287
2015 314
2016 300
2017 304
2018 377
2019 418
2020 434
2021 491
2022 544
2023 596
2024 182

Text availability

Article attribute

Article type

Publication date

Search Results

5,131 results

Results by year

Filters applied: . Clear all
Page 1
Vaccines' New Era-RNA Vaccine.
Zhou W, Jiang L, Liao S, Wu F, Yang G, Hou L, Liu L, Pan X, Jia W, Zhang Y. Zhou W, et al. Among authors: jia w. Viruses. 2023 Aug 18;15(8):1760. doi: 10.3390/v15081760. Viruses. 2023. PMID: 37632102 Free PMC article. Review.
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations.
Ni Y, Qian L, Siliceo SL, Long X, Nychas E, Liu Y, Ismaiah MJ, Leung H, Zhang L, Gao Q, Wu Q, Zhang Y, Jia X, Liu S, Yuan R, Zhou L, Wang X, Li Q, Zhao Y, El-Nezami H, Xu A, Xu G, Li H, Panagiotou G, Jia W. Ni Y, et al. Among authors: jia w. Cell Metab. 2023 Sep 5;35(9):1530-1547.e8. doi: 10.1016/j.cmet.2023.08.002. Cell Metab. 2023. PMID: 37673036 Clinical Trial.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: jia w. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Live birth of chimeric monkey with high contribution from embryonic stem cells.
Cao J, Li W, Li J, Mazid MA, Li C, Jiang Y, Jia W, Wu L, Liao Z, Sun S, Song W, Fu J, Wang Y, Lu Y, Xu Y, Nie Y, Bian X, Gao C, Zhang X, Zhang L, Shang S, Li Y, Fu L, Liu H, Lai J, Wang Y, Yuan Y, Jin X, Li Y, Liu C, Lai Y, Shi X, Maxwell PH, Xu X, Liu L, Poo M, Wang X, Sun Q, Esteban MA, Liu Z. Cao J, et al. Among authors: jia w. Cell. 2023 Nov 9;186(23):4996-5014.e24. doi: 10.1016/j.cell.2023.10.005. Cell. 2023. PMID: 37949056
5,131 results